ClinConnect ClinConnect Logo
Search / Trial NCT06372600

Effect of Extracorporeal Shock Wave Combined With Autologous Platelet-rich Plasma Injection on Rotator Cuff Calcific Tendinitis

Launched by XIALI XUE · Apr 17, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Rotator Cuff Calcifying Tendinitis Prp Esw

ClinConnect Summary

This clinical trial is looking at a new way to help people with a painful shoulder condition called rotator cuff calcific tendinitis. This condition happens when calcium deposits form in the shoulder tendons, causing significant pain and discomfort. The study will test a combination of two treatments: extracorporeal shock wave therapy, which uses sound waves to reduce pain and promote healing, and an injection of platelet-rich plasma (PRP) from the patient's own blood, which can help repair damage in the shoulder. The goal is to see if these treatments can help patients feel better and return to their normal activities more quickly.

To participate in this trial, individuals need to be between 40 and 60 years old and have been diagnosed with rotator cuff calcific tendinitis for the first time. They should be experiencing persistent shoulder pain confirmed by imaging tests like X-rays or MRIs. However, people with certain other shoulder injuries, prior surgeries, or serious health issues will not be eligible to join. If selected, participants can expect to receive the combined treatments and be closely monitored for their pain levels and recovery progress throughout the study. This research aims to provide new insights and options for those suffering from this challenging condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Meet the diagnostic criteria for rotator cuff calcific tendonitis, aged between 40 and 60 years old
  • Persistent pain in the affected shoulder, with obvious tenderness under the acromion and rotator cuff, as confirmed by X-ray and Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) examination showed one or more round-shaped high-density calcium salt deposits near the greater tuberosity of the humerus
  • All were diagnosed for the first time
  • Complaints of severe pain in the shoulder joint, obvious
  • Exclusion Criteria:
  • Combined with rotator cuff trauma, long head of biceps tendonitis and other shoulder joint diseases
  • Past combined history of shoulder joint surgery
  • Patients with internal fixation of the shoulder joint
  • Shoulder joint combined with infection, Tumors and other lesions
  • Combined with severe heart, liver, and kidney dysfunction
  • Do not agree to participate in the study or fail to sign the informed consent form.

About Xiali Xue

Xiali Xue is a leading clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on developing novel therapeutics and interventions, Xiali Xue collaborates with a network of renowned research institutions and healthcare professionals to conduct rigorous clinical trials. The organization is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the safety and efficacy of its studies. Through its comprehensive approach and dedication to scientific excellence, Xiali Xue aims to contribute significantly to improving patient outcomes and transforming healthcare practices.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported